Gossamer Bio to present at Cantor Global Healthcare conference
Gossamer Bio, Inc. said it will present at the Cantor Global Healthcare Conference. The company is focused on seralutinib for pulmonary arterial hypertension (PAH) and PH-ILD.
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced tha…